DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Sorich MJ, Wiese MD, Rowland A, Kichenadasse G, McKinnon RA, Karapetis CS.
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials.
Ann Oncol 2015;
26 (01) 13-21
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.